Skip Navigation


Rheumatology Advance Access originally published online on August 7, 2008
Rheumatology 2008 47(10):1543-1547; doi:10.1093/rheumatology/ken316
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
47/10/1543    most recent
ken316v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sokka, T.
Right arrow Articles by Pincus, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sokka, T.
Right arrow Articles by Pincus, T.
Related Collections
Right arrow Pharmacology
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Ascendancy of weekly low-dose methotrexate in usual care of rheumatoid arthritis from 1980 to 2004 at two sites in Finland and the United States

T. Sokka1 and T. Pincus2

1Jyväskylä Central Hospital, Jyväskylä, Finland and 2NYU Hospital for Joint Diseases, NY, USA.

Correspondence to: T. Pincus, NYU Hospital for Joint Diseases, 301 East 17 Street, New York, NY 10003, USA. E-mail: tedpincus{at}gmail.com


  Abstract

Objectives. To analyse consecutive patients with RA in usual rheumatology care between 1980 and 2004 at two settings for the proportion of patients taking MTX, interval from patient presentation to MTX prescription and radiographic and functional status outcomes.

Methods. Longitudinal study of all patients seen in usual care between 1980 and 2004, 1982 consecutive patients in Jyväskylä, Finland and 738 consecutive patients in Nashville, TN, USA. Clinical status was assessed as Larsen radiographic scores in Jyväskylä and modified health assessment questionnaire (MHAQ) in Nashville.

Results. The probability of initiating MTX within 5 yrs after presentation increased from <5% in Jyväskylä before 1989 to >90% in 2000–04, and from 25% in Nashville in 1980–84 to >90% since 1995. The median interval from presentation to MTX initiation in Jyväskylä was 14 yrs in 1980–84 vs 8.6 in 1985–89, 4.5 in 1990–94, 1.8 in 1995–99 and <1 yr in 2000–05; in Nashville, median intervals were 8.6 yrs in 1980–84, 4.4 years in 1985–89, and <2 months in 1990–95, 1995–2000 and 2000–05. Patient outcomes were substantially improved in both settings: in Jyväskylä, mean 5-yr Larsen radiographic scores (0–100) were 15.7 in 1980–84 vs 4.0 in 1995–99; in Nashville, mean MHAQ scores (0–3) for physical function were 1.13 in 1980–84 vs 0.57 in 2000–04.

Conclusion. Early MTX in usual clinical care of RA increased from <5% in 1980 to >90% in 2004. Over this period, substantially improved outcomes were seen, most of which antedated biological agents.

KEY WORDS: Rheumatoid arthritis, Health assessment questionnaire, Modified health assessment questionnaire, Methotrexate, Outcomes

Submitted 22 February 2008; revised version accepted 7 July 2008.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.